Calton & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $362K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $802K | Buy |
|
|||||
|
2024
Q2 | $407K | Sell |
|
|||||
|
2024
Q1 | $585K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $206K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $258K | Sell |
|
|||||
|
2021
Q3 | $356K | Sell |
|
|||||
|
2021
Q2 | $439K | Buy |
|
|||||
|
2021
Q1 | $409K | Sell |
|
|||||
|
2020
Q4 | $525K | Sell |
|
|||||
|
2020
Q3 | $616K | Sell |
|
|||||
|
2020
Q2 | $674K | Buy |
|
|||||
|
2020
Q1 | $597K | Sell |
|
|||||
|
2019
Q4 | $830K | Buy |
|
|||||
|
2019
Q3 | $406K | Sell |
|
|||||
|
2019
Q2 | $388K | Buy |
|
|||||
|
2019
Q1 | $405K | Sell |
|
|||||
|
2018
Q4 | $503K | Buy |
|
|||||
|
2018
Q3 | $524K | Sell |
|
|||||
|
2018
Q2 | $673K | Sell |
|
|||||
|
2018
Q1 | $1.11M | Buy |
|
|||||
|
2017
Q4 | $1.05M | Buy |
|